title: Selective increases in phosphoinositide signaling activity and G protein levels in postmortem brain from subjects with schizophrenia or alcohol dependence.
abstract: Comparisons of the activity of the G protein-mediated phosphoinositide signal transduction system and of G protein levels were made in two regions of frontal cortex from eight schizophrenic, alcohol-dependent, and control subjects. G protein-mediated phosphoinositide hydrolysis was measured by stimulating cortical membranes incubated with [3H]phosphatidylinositol with 0.3-10 microM guanosine 5'-O-(3-thio)triphosphate (GTPgammaS). In frontal cortex areas 8/9, GTPgammaS-induced phosphoinositide hydrolysis was 50% greater in schizophrenic than control or alcohol-dependent subjects, whereas there were no differences among these groups of subjects in the response to GTPgammaS in frontal cortex area 10. Agonists for dopaminergic, cholinergic, purinergic, serotonergic, histaminergic, and glutamatergic receptors coupled to the phosphoinositide signaling system increased [3H]phosphatidylinositol hydrolysis in a GTPgammaS-dependent manner. Responses to most agonists were similar in all three subject groups in both cortical regions, with the largest difference being a 40% greater response to dopaminergic receptor stimulation in frontal cortex 8/9 from schizophrenic subjects. Measurements of the levels of phospholipase C-beta, and of alpha-subunits of Gq, Go, Gi1, Gi2, and Gs, made by immunoblot analyses revealed no differences among the groups of subjects except for increased G alpha(o) in schizophrenic subjects and increased G alpha(o) and G alpha(i1) in alcohol-dependent subjects. These results demonstrate that schizophrenia is associated with increased activity of the phosphoinositide signal transduction system and increased levels of G alpha(o), whereas the phosphoinositide system was unaltered in alcohol dependence, but G alpha(o) and G alpha(i1) were increased.
authors.affiliation: Department of Psychiatry and Behavioral Neurobiology, University of Alabama at Birmingham, 35294-0017, USA.
authors.forename: R S
authors.initials: RS
authors.lastname: Jope
authors.forename: L
authors.initials: L
authors.lastname: Song
authors.forename: C A
authors.initials: CA
authors.lastname: Grimes
authors.forename: M A
authors.initials: MA
authors.lastname: Pacheco
authors.forename: G E
authors.initials: GE
authors.lastname: Dilley
authors.forename: X
authors.initials: X
authors.lastname: Li
authors.forename: H Y
authors.initials: HY
authors.lastname: Meltzer
authors.forename: J C
authors.initials: JC
authors.lastname: Overholser
authors.forename: C A
authors.initials: CA
authors.lastname: Stockmeier
mesh_terms: D000328:Adult; D000437:Alcoholism / Q000378:metabolism*; D001344:Autopsy; D002462:Cell Membrane / Q000378:metabolism; D002540:Cerebral Cortex / Q000378:metabolism; D005260:Female; D005625:Frontal Lobe / Q000378:metabolism* / Q000473:pathology; D019204:GTP-Binding Proteins / Q000378:metabolism*; D016244:Guanosine 5'-O-(3-Thiotriphosphate) / Q000494:pharmacology; D006801:Humans; D008297:Male; D008875:Middle Aged; D010716:Phosphatidylinositols / Q000378:metabolism*; D012016:Reference Values; D012559:Schizophrenia / Q000378:metabolism*; D015398:Signal Transduction
chemical_list: D010716:Phosphatidylinositols; D016244:Guanosine 5'-O-(3-Thiotriphosphate); D019204:GTP-Binding Proteins